BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18185140)

  • 1. Short-term complications of intravitreal injection of triamcinolone acetonide.
    Roth DB; Realini T; Feuer WJ; Radhakrishnan R; Gloth J; Heimmel MR; Fechtner RD; Yarian DL; Green SN
    Retina; 2008 Jan; 28(1):66-70. PubMed ID: 18185140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
    Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
    Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term incidence and timing of intraocular hypertension after intravitreal triamcinolone acetonide injection.
    Roth DB; Verma V; Realini T; Prenner JL; Feuer WJ; Fechtner RD
    Ophthalmology; 2009 Mar; 116(3):455-60. PubMed ID: 19157561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
    Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
    Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of intravitreal steroid injections.
    Reichle ML
    Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Jonas JB; Degenring RF; Kreissig I; Akkoyun I; Kamppeter BA
    Ophthalmology; 2005 Apr; 112(4):593-8. PubMed ID: 15808249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of intravitreal triamcinolone for the treatment of macular edema secondary to branch retinal vein occlusion in eyes with or without grid laser photocoagulation.
    Cakir M; Dogan M; Bayraktar Z; Bayraktar S; Acar N; Altan T; Kapran Z; Yilmaz OF
    Retina; 2008 Mar; 28(3):465-72. PubMed ID: 18327140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse events after intravitreal triamcinolone in patients with and without uveitis.
    Galor A; Margolis R; Brasil OM; Perez VL; Kaiser PK; Sears JE; Lowder CY; Smith SD
    Ophthalmology; 2007 Oct; 114(10):1912-8. PubMed ID: 17908594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intravitreal triamcinolone acetonide on intraocular pressure.
    Bakri SJ; Beer PM
    Ophthalmic Surg Lasers Imaging; 2003; 34(5):386-90. PubMed ID: 14509462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
    Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
    J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal triamcinolone acetonide and intraocular pressure.
    Smithen LM; Ober MD; Maranan L; Spaide RF
    Am J Ophthalmol; 2004 Nov; 138(5):740-3. PubMed ID: 15531307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide.
    Agrawal S; Agrawal J; Agrawal TP
    Am J Ophthalmol; 2004 Oct; 138(4):679-80. PubMed ID: 15488813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.
    Roesel M; Gutfleisch M; Heinz C; Heimes B; Zurek-Imhoff B; Heiligenhaus A
    Ophthalmic Res; 2009; 42(2):81-6. PubMed ID: 19478546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Pizzimenti JJ; Nickerson MM; Pizzimenti CE; Kasten-Aker AG
    Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cataract progression after intravitreal triamcinolone injection.
    CekiƧ O; Chang S; Tseng JJ; Akar Y; Barile GR; Schiff WM
    Am J Ophthalmol; 2005 Jun; 139(6):993-8. PubMed ID: 15953428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of a topical dexamethasone provocative test before intravitreal triamcinolone acetonide injection.
    Breusegem C; Vandewalle E; Van Calster J; Stalmans I; Zeyen T
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):573-6. PubMed ID: 18824737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sterile endophthalmitis following intravitreal injection of triamcinolone acetonide.
    Wang LC; Yang CM
    Ocul Immunol Inflamm; 2005; 13(4):295-300. PubMed ID: 16159720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of patient age as a risk factor for intraocular pressure elevation after intravitreal triamcinolone.
    Shukla D; Vidhya N; Prasad NM; Mahalakshmi R; Kolluru C; Krishnadas R
    Am J Ophthalmol; 2007 Sep; 144(3):453-4. PubMed ID: 17765428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of selective laser trabeculoplasty on intraocular pressure in patients with intravitreal steroid-induced elevated intraocular pressure.
    Rubin B; Taglienti A; Rothman RF; Marcus CH; Serle JB
    J Glaucoma; 2008; 17(4):287-92. PubMed ID: 18552614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.